Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.
{iframe}http://www.lupin.com/lupin-launches-generic-safyral-tablets-in-the-us.php{/iframe}